Variations in Management and Clinical Outcomes for Children With Diabetic Ketoacidosis in an Academic Pediatric

John Nathan Freeman1, Callie Giroux2, Timothy King3

  • 1From the Division of Pediatric Emergency Medicine, Department of Pediatrics.

PubMed

Insights

Pediatric diabetic ketoacidosis (DKA) management varied significantly between community and pediatric emergency departments. Community sites showed deviations from evidence-based guidelines, leading to longer treatment times for DKA patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Endocrinology
  • Quality Improvement Science

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of diabetes in children.
  • Standardized, evidence-based guidelines exist for DKA management.
  • Variations in care delivery may impact patient outcomes.

Purpose of the Study:

  • To compare the initial management of pediatric DKA patients presenting to community emergency departments (OSH) versus a tertiary pediatric emergency department (PED).
  • To identify variations in adherence to evidence-based guidelines.
  • To compare clinical outcomes between the two settings.

Main Methods:

  • Retrospective study of pediatric patients (≤18 years) with DKA over 3 years.
  • Comparison of treatments including fluid management, insulin, and sodium bicarbonate.
  • Analysis of clinical outcomes such as time to anion gap correction, insulin infusion, and hospital discharge.

Main Results:

  • OSH patients presented with more severe acidosis and larger anion gaps.
  • OSH patients were more likely to receive fluid boluses, sodium bicarbonate, and IV bolus insulin.
  • OSH patients had longer times for anion gap correction, insulin infusion, and hospital discharge.
  • Incidence of hypokalemia, hypoglycemia, cerebral edema, and mortality were similar between groups.

Conclusions:

  • Significant variations exist in pediatric DKA management between OSH and PED settings.
  • OSH management often deviated from evidence-based pathways.
  • Statewide quality improvement initiatives are recommended to standardize care and improve outcomes for pediatric DKA patients.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
926
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
571